<DOC>
	<DOCNO>NCT00879749</DOCNO>
	<brief_summary>The main purpose study determine safety weekly injection Nexvax2 give three week patient coeliac disease gluten-free diet . The second purpose study compare immune response three week study period coeliac disease patient give Nexvax2 compare give saline .</brief_summary>
	<brief_title>Safety Study Nexvax2 Subjects With Coeliac Disease</brief_title>
	<detailed_description />
	<mesh_term>Celiac Disease</mesh_term>
	<criteria>Key 1 . Age 18 60 year ( inclusive ) 2 . Have coeliac disease meeting follow criterion : Principal Investigator satisfy coeliac disease correctly diagnose , HLA DQ2 genotype ( HLA DQA1*05 DQB1*02 , homo heterozygous ) , know suspect gluten exposure 2 month prior enrolment prescribed intend follow glutenfree diet least one year antibodies tissue transglutaminase ( tTG ) IgA and/or deamidated gliadin peptide ( DGP ) IgA IgG within normal reference range time screen . 3 . Either male nonlactating , nonpregnant female postmenopausal , sterile use least two acceptable highly effective birth control method . Key 1 . Subjects possess gene encode HLA DQ8 ( either DQA1*03 DQB1*0302 ) . 2 . Uncontrolled complication coeliac disease , opinion Investigator , would impact immune response pose increase risk subject . 3 . Systemic biological agent le 6 month prior Day 1 . 4 . Receipt systemic immunomodulatory agent experimental drug le 30 day prior Day 1 . 5 . Any following laboratory abnormality Screening : ALT , AST alkaline phosphatase ( ALP ) &gt; 1.5 time upper limit normal ( ULN ) Calculated creatinine clearance &lt; 80 mL/min Haemoglobin ( Hb ) outside normal range Platelet count &lt; 125 x 109/L Serum potassium outside normal range White blood cell ( WBC ) count outside normal range Thyroid stimulate hormone ( TSH ) outside normal range Any clinically significant abnormal lab value , determine Clinical Investigator . 6 . Subjects smoke smoke past 3 month . 7 . Positive pregnancy test Screening Baseline . 8 . History medically significant condition consider Investigator adversely affect participation trial . 9 . Noncompliance gluten free diet flare coeliac disease symptom Screening Baseline . 10 . Clinically relevant abnormality ECGs .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>